老年心脏病学杂志（英文版）2021，Vol.18Issue(10)：783-795,13.
Impact of SGLT2 inhibitors on major clinical events and safety outcomes in heart failure patients:a meta-analysis of randomized clinical trials
Impact of SGLT2 inhibitors on major clinical events and safety outcomes in heart failure patients:a meta-analysis of randomized clinical trials
George Bazoukis 1Stamatis S.Papadatos 2Costas Thomopoulos 3Gary Tse 4Stefanos Cheilidis 5Konstantinos Tsioufis 6Dimitrios Farmakis5
作者信息
- 1. Department of Cardiology,Larnaca General Hospital,Larnaca,Cyprus
- 2. Department of Anatomy,Histology and Embryology,Medical School,University of Ioannina,Ioannina,Greece
- 3. Department of Cardiology,Helena Venizelou Hospital,Athens,Greece
- 4. Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease,Department of Cardiology,Tianjin Institute of Cardiology,Second Hospital of Tianjin Medical University,Tianjin,China
- 5. University of Cyprus Medical School,Nicosia,Cyprus
- 6. First Cardiology Clinic,Hippokration Hospital,Athens University,Athens,Greece
- 折叠
引用本文复制引用
George Bazoukis,Stamatis S.Papadatos,Costas Thomopoulos,Gary Tse,Stefanos Cheilidis,Konstantinos Tsioufis,Dimitrios Farmakis..Impact of SGLT2 inhibitors on major clinical events and safety outcomes in heart failure patients:a meta-analysis of randomized clinical trials[J].老年心脏病学杂志（英文版）,2021,18(10):783-795,13.
